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Abstract
The observation that mice with a selective ablation of the androgen receptor (AR) in Sertoli cells (SC) (SCARKO mice) display
a complete block in meiosis supports the contention that SC play a pivotal role in the control of germ cell development by
androgens. To delineate the physiological and molecular mechanism responsible for this control, we compared tubular
development in pubertal SCARKO mice and littermate controls. Particular attention was paid to differences in SC
maturation, SC barrier formation and cytoskeletal organization and to the molecular mediators potentially involved.
Functional analysis of SC barrier development by hypertonic perfusion and lanthanum permeation techniques and
immunohistochemical analysis of junction formation showed that SCARKO mice still attempt to produce a barrier
separating basal and adluminal compartment but that barrier formation is delayed and defective. Defective barrier
formation was accompanied by disturbances in SC nuclear maturation (immature shape, absence of prominent, tripartite
nucleoli) and SC polarization (aberrant positioning of SC nuclei and cytoskeletal elements such as vimentin). Quantitative
RT-PCR was used to study the transcript levels of genes potentially related to the described phenomena between day 8 and
35. Differences in the expression of SC genes known to play a role in junction formation could be shown from day 8 for
Cldn11, from day 15 for Cldn3 and Espn, from day 20 for Cdh2 and Jam3 and from day 35 for ZO-1. Marked differences were
also noted in the transcript levels of several genes that are also related to cell adhesion and cytoskeletal dynamics but that
have not yet been studied in SC (Actn3, Ank3, Anxa9, Scin, Emb, Mpzl2). It is concluded that absence of a functional AR in SC
impedes the remodeling of testicular tubules expected at the onset of spermatogenesis and interferes with the creation of
the specific environment needed for germ cell development.
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Introduction
Androgens play a pivotal role in the control of spermatogenesis.
Under a number of conditions they are even able to maintain
fertility in the virtual absence of follicle stimulating hormone (FSH)
[1–5]. Interestingly, most data indicate that the androgen receptor
(AR) is not expressed in germ cells (GC) and that GC can develop
normally in the absence of cell-autonomous AR expression [6–9].
This indicates that androgens affect GC development indirectly by
acting on somatic testicular cells. The development of animals with
cell-selective knockouts of the AR in various somatic testicular cells
points to the Sertoli cell (SC) as the key mediator of the effects of
androgens in the control of spermatogenesis. In fact, mice with a
selective knockout of the AR in SC (SCARKO) develop a
complete block in meiosis [10,11]. Data on the consequences of a
knockout of the AR in peritubular myoid cells (PTM) are more
controversial. Whereas original studies suggested that the latter
knockout has only minor effects on GC development [12], more
recent data indicate that those studies mainly targeted vascular
smooth muscle cells and that more appropriate targeting of the AR
in PTM (using a line of mice expressing Cre more specifically in
PTM) causes major disturbances in spermatogenesis [13].
Notably, secondary disturbances in SC and Leydig cells (LC)
function appear to be one consequence of the ablation of the AR
in PTM highlighting again the carefully balanced dialogue that
exists between the different somatic cell types within the testis and
the pivotal role the SC plays in orchestrating full, functional
maturation of the GC cohort.
Although our studies as well as those of others [1,10,11,14]
agree that AR-dependent modulation of SC function plays a
critical regulatory role in supporting GC as they mature within the
seminiferous epithelium, we are still some way from fully
understanding the molecular mediators and pathways by which
androgens orchestrate the relationship between SC and GC.
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Unfortunately, studies on isolated and cultured SC or SC-lines
have proven of limited use since these cells appear to de-
differentiate in the absence of GC, exhibit a marked reduction in
androgen responsiveness and lack the expression of prototypic
androgen-regulated genes such as reproductive homeobox 5
(Rhox5) [15,16]. Various attempts have been made to identify
androgen-regulated genes under in vivo conditions that maintain
the normal cellular microenvironment of the SC. Examples
include: microarray analysis of the impact of exogenously
administered androgens on gene expression in the testis of
prepubertal mice or mice that are hypogonadal due to a large
deletion of the gonadotropin-releasing hormone 1 gene (Gnrh1; hpg
mice) [17,18] and identification of testicular genes that are
differentially expressed (and putatively androgen regulated) in
SCARKO mice or mice with a ubiquitous inactivation of the AR
(testicular feminization mutation; Tfm) versus wild-type controls
[19–21]. Although there was very limited overlap between the
series of androgen-regulated genes identified in these studies, genes
related to particular processes and functions (including: protease
balance, cell interactions, cytoskeletal dynamics) were prominently
present [19–22].
Whereas in other testicular somatic cells (PTM, interstitial cells)
AR expression is already established during embryonic life, AR
expression in SC starts quite late (postnatal day 4–5 in rats and
mice, 4–8 years of age in boys) [23–25]. Recent data indicate that
very soon after the appearance of the AR selected genes become
activated in mouse SC [23] and that on day 10 the expression of as
many as 692 genes is affected by the presence of an active AR in
SC [19]. Functional analysis revealed a prominent presence of
genes encoding proteases and protease inhibitors, cell adhesion
molecules, extracellular matrix elements and cytoskeletal mole-
cules potentially related to tubular restructuring and changes in
cell junction dynamics. Based upon this observation the hypothesis
was advanced that, during early puberty, androgens may
contribute to the creation of a specific environment needed for
GC development [19]. To test this hypothesis we compared
tubular development, SC maturation, cytoskeletal changes and
expression of genes potentially related to these events in wild type
and SCARKO mice. Particular attention was devoted to the
development of the SC (blood-testis) barrier, a structure that
ultimately divides the tubules into a basal compartment (contain-
ing mainly spermatogonia) and an adluminal compartment
(providing the specific microenvironment needed for meiotic and
postmeiotic stages of germ cell development) but that also permits
controlled passage of preleptotene spermatocytes from the basal to
the adluminal compartment. The mature SC barrier is a complex,
well organized and dynamic structure containing tight junction
proteins (e.g. occludins, claudins, junction adhesion molecules),
anchoring junction proteins (e.g. N-cadherin, espin) and gap
junction proteins (e.g. connexin 43). A network of adaptor proteins
(e.g. zonula occludens protein 1, -2 and 3) links these membranous
components to intermediate filaments and to the filamentous actin
(F-actin) cytoskeleton [26,27]. A role for AR regulated gene
expression in the formation of the SC barrier has been inferred
from reports indicating that it is functionally defective in Tfm mice
[28] and also in Arflox(ex1-neo)/Y; AMH-Cre mice, a mouse model
with an ablation of the AR in SC as well as a marked reduction in
AR expression in all other AR expressing cells [29,30]. However in
SCARKO mice some tubules within the adult testis contain an
identifiable lumen or small amounts of fluid accumulation, calling
into question the requirement of the AR in SC for the formation of
a functional SC barrier [10].
A detailed analysis of tubular development in SCARKO and
control mice shows that ablation of the AR in SC results in delayed
and defective formation of the SC barrier. This defect is accompanied
by defective SC maturation including signs of nuclear immaturity, a
failure of the nuclei to descend to the base of the tubules and
disturbed development of the cytoskeleton. The observed morpho-
logical defects are accompanied by disturbances in the expression and
localization of previously identified and novel molecules related to cell
adhesion/interaction and cytoskeletal dynamics.
Materials and Methods
Ethics statement
All animals were treated according to the National Institutes of
Health Guide for the Care and Use of Laboratory Animals, and all
experiments were approved by the ‘‘Ethical Committee Animal
Tests’’ of the Catholic University of Leuven (project licence
number 004/2006).
Generation of transgenic mice
Mice with a Sertoli cell-selective knockout of the AR (SCARKO)
were generated by crossing female mice (98% CD1) heterozygous
for a floxed AR allele (ARflox/+) with male mice (C57BL/6SJL)
carrying a Cyclization Recombination (Cre) recombinase of which
the expression is controlled by the SC-specific anti-Mu¨llerian
hormone promotor (AMH-Cre) transgene [31], kindly provided by
Dr. F. Guillou (Tours, France). Littermate males carrying only the
AMH-Cre transgene were used as a control for the SCARKO
animals. The genotype of control and SCARKO animals was
confirmed by PCR on tailtips as described elsewhere [10].
Hypertonic perfusions
Hypertonic perfusions of testes were performed essentially as
described [32]. Peripubertal (10-, 15-, 25- and 35-day-old) and adult
($50-day-old) mice (at least 3 SCARKOs and 3 controls at each
age) were anaesthetized with a ketamin-xylazine-heparin solution
(100 mg/kg body weight, 15 mg/kg body weight and 1000 IU/kg
body weight, respectively) injected intraperitoneally 20 min prior to
perfusion. Testes were perfused by intracardiac injection of 10%
glucose in 0.9%NaCl for 10 min followed by 30 min perfusion with
fixative containing 10% glucose and 3% glutaraldehyde buffered in
0.05 M sodium cacodylate (pH 7.4). After perfusion, testes were
removed and postfixed in the above mentioned fixative. After 24 h,
testes were washed in 70% ethanol, followed by several washes in
100% ethanol. After dehydration, testes were embedded in methyl
methacrylate (MMA), 2 mm sections were cut with a Leica RM
2155 microtome with a tungsten carbide D-profile microtome knife
and stained with toluidine blue.
Immersion fixation with lanthanum and electron
microscopic evaluation
Fixative containing lanthanum (pH 7.3) was prepared essen-
tially as described [33]. Lanthanum hydroxide (2%; pH 7.8 with
0.01 N NaOH) was gently mixed with an equal volume of 4%
glutaraldehyde in 0.2 M sodium cacodylate (pH 7.3 with 1N
HCl). Mice were killed by cervical dislocation, testes were removed
and decapsulated and pre-fixed for 5 min in fixative containing
lanthanum. After pre-fixation, testes were cut into small pieces (2–
3 mm3) and immersed in the fixative containing lanthanum for
5 h at room temperature. Afterwards, samples were rinsed and
stored in buffered lanthanum solution (1% lanthanum in 0.1 M
sodium cacodylate, pH 7.3) at 4uC until further processing.
For transmission electron microscopy analysis testis samples
were post-fixed in 1% osmium tetroxide in sodium cacodylate,
pH 7.2 for 2 h at 4uC and immersed in 2% uranyl acetate solution
at 4uC overnight. The samples were dehydrated in ethanol and
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embedded in Epon 812-Araldite 502. Thin sections were then
routinely prepared for light microscopy analysis. Ultra-thin
sections (70–80 nm) from the previously selected areas of the
testes were mounted on 200-mesh uncoated copper grids, stained
with 2% uranyl acetate in distilled water for 1 h and 0.5% lead
citrate in distilled water for 30 min. These grids were examined in
a 100 CX-II Jeol transmission electron microscope (80 kV).
Immunohistochemistry
Testes derived from 20-, 25-, 35- and 50-day-old SCARKO and
control mice were either fixed in Bouin’s fluid for 6 hours and
stored in 70% ethanol at 4uC or frozen in isopentane and liquid
nitrogen and stored at 280uC until further processing.
Fluorescent colocalization of zonula occludens 1 (ZO-1) and F-
actin were carried out on sections of frozen testes. Frozen testes
were embedded in Neg-50 Frozen Section Medium (Thermo
Fisher Scientific), cut at 10 mm with a cryostat and mounted on
SuperfrostH Plus slides (Thermo Scientific). Sides were fixed for
10 min at room temperature (RT) with 4% paraformaldehyde and
washed 2 times with 16Dulbecco’s Phosphate Buffered Saline
(DPBS; Invitrogen). Afterwards, sections were permeabilized with
0.5% Triton X-100 for 15 min and washed 3 times with DPBS.
Next, 4 drops of Image-iTTM Fx Signal Enhancer (Invitrogen)
were applied upon tissue sections for 30 min (at RT) and again
washed 3 times with 16DPBS. Subsequently sections were blocked
(30 min; RT) with 16DPBS supplemented with 10% normal goat
serum and 1% BSA, washed 1 time with 16DPBS followed by
overnight incubation with rabbit anti-ZO-1 antibody (1/500; 40-
2200 from Invitrogen) in blocking buffer. Before and after
incubation with secondary antibody (Alexa fluorH 488 goat anti-
rabbit IgG (H+L) at 2 mg/ml; A-11008 from Invitrogen) and
phalloidin-TRITC (P1951 from SIGMA at 0.2 mg/ml) for 1 hour
at RT in blocking buffer, slides were washed 3 times in 16DPBS.
Next, slides were incubated for 10 min with 49,69-diamino-2-
phenylindole (DAPI) (5 mg/ml; D1306 from Invitrogen) in
16DPBS, once more washed 3 times with 16DPBS and mounted
in Fluorescent Mounting Medium (S3023, DakoCytomation).
Fluorescent images were captured using a Leica DMR microscope
with a Sony DXC-9100P camera.
Fluorescent colocalization of vimentin (VIM) and GATA binding
protein 1 (GATA1) or connexin 43 (CX43) and espin (ESPN) were
carried out on fixed tissue sections using standard protocols [34,35].
All washes were carried out using phosphate buffered saline and
negative controls were performed using serum from the same
species in which primary antibodies were raised. Briefly, sections
were incubated overnight at 4uC with anti-VIM (1/100; ab7783
from Abcam) or anti-CX43 (1/100; 71-0700 from Invitrogen),
washed and incubated with the appropriate secondary antibodies
(Alexa fluorH 488 goat anti-rabbit at 1/200 from Molecular Probes
and biotinylated goat anti-rabbit at 1/500 from Dako respectively).
Sections incubated with anti-CX43 were also incubated with
strepavidin-conjugated alexa 546 (Molecular Probes, Poortgebouw,
Holland). All non-specific binding sites were blocked with
appropriate normal serum/PBS/BSA for 30 min, then sections
were again incubated overnight this time with anti-GATA1 (1/30;
sc266 from Santa Cruz Biotechnology) or anti-ESPN (1/30; 611656
from BD Bioscience) respectively. After further washes these
antibodies were detected with suitable secondary antibodies (rabbit
anti-rat peroxidase at 1/200 from Sigma and Alexa fluorH 488 goat
anti-mouse at 1/200 from Molecular Probes respectively). Sections
incubated with anti-GATA1 were also incubated with tyramide
Cy3 (TSA plus cyanine 3 system from Perkin-Elmer Life Sciences,
Boston, MA). Sections were counterstained by incubating them for
10 min with DAPI (Sigma) diluted 1/1000 in PBS and mounted in
Permafluor (Beckman Coulter, High Wycombe, UK) aqueous
mounting medium.
Tissue sections from 3 animals in each group were run
simultaneously. To ensure direct comparability of staining intensi-
ties, one section each from control and SCARKO mice were
mounted on the same slide.
RNA Extraction and quantitative RT-PCR
RNA was prepared from testes derived form SCARKO and
control animals at the indicated ages. Mice were killed by cervical
dislocation, testes were snap-frozen in liquid nitrogen immediately
after removal and stored at 280uC. Before RNA extraction, testes
were weighed and homogenized in a Dounce homogenizer (Kontes
Co., Vineland, NJ). RNA was isolated with the RNeasyH Mini kit
(Qiagen, Chatsworth, CA) according to the manufacturer’s instruc-
tions, encompassing an on-column deoxyribonuclease I (DNase I)
treatment of the RNA. Five ng of luciferase mRNA (Promega,
Madison, WI) was added to the whole testis sample at the start of the
RNA extraction procedure to control for the efficiency of RNA
extraction, RNA degradation and the reverse transcription step and
to allow specific mRNA levels to be expressed per testis [36].
cDNA was synthesized from 1 mg RNA using Superscript II
RT, RNaseOUTHTM and random hexamer primers (Invitrogen
Life Technologies, Inc) according to the manufacturer’s protocol.
For quantification of gene expression, the 7500 Fast Real-Time
PCR system (Applied Biosystems, Foster City, CA) was used
running the ‘Fast RT-PCR’ protocol (2 min at 50uC, 2 min at
95uC and 40 cycles of 3 sec at 95uC and 30 sec at 60uC).
Quantitative real-time PCR (qPCR) components for synaptonemal
complex protein 3 (Sycp3), steroid 17-a- hydroxylase/17,20-lyase
(Cyp17a1), claudin 11 (Cldn11), claudin 3 (Cldn3), ZO-1, luciferase
and 18S ribosomal RNA (Rn18S) were obtained from the PlatinumH
SYBRH Green qPCR SuperMix-UDG kit (Invitrogen). For qPCR
assays with fluorescent probe detection (Rhox5, actinin a3 (Actn3),
ankyrin3 (Ank3), annexin A9 (Anxa9), scinderin (Scin), embigin (Emb),
myelin protein zero-like2 (Mpzl2), occludin (Ocln), junction adhesion molecule
3 (Jam3), Vim, Cx43, Espn and N-cadherin (Cdh2)) the TaqManH Fast
Universal PCR Master Mix (2x) (Applied Biosystems) was used as
described elsewhere [23]. Sequences of primers, probes and
identification numbers of TaqManH Gene Expression Assays
(Applied Biosystems) are described in Table 1 and Table 2.
The quantity of target mRNA of cell adhesion molecules and
cytoskeletal elements in whole testis extracts of SCARKO and
control mice was normalized to an external luciferasemRNA standard,
added before RNA extraction (as described above). For localization
of transcripts in different cell fractions, the quantity of target mRNA
was normalized to Rn18S. Results were quantified by the comparative
threshold method [37] and DDCt values were expressed relative to
the average value of the control on day 10 (arbitrarily given a value of
100) for the evaluation of expression levels from day 8 to day 35. For
the experiments in which the SC where enriched, DDCt values were
expressed relative to the average value of whole testis extract
(arbitrarily given a value of 100). All samples were run in triplicate.
Microarray data reflecting the expression pattern of cell adhesion
molecules and cytoskeletal elements (day 8–day 20) were obtained as
described previously [19]. Raw data of this microarray study are
available at the GEO website (GSE2259).
Statistical analysis
qPCR time-studies were analysed by a two-way ANOVA supple-
mented with a Fisher multiple comparison test using NCSS2000
software (NCSS Statistical Analysis and Data Analysis Software,
Kaysville, UT, USA). A p-value # 0.05 was considered statistically
significant.
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Results
Evidence for marked differences in barrier function in
SCARKO and control testes
We have previously reported that the reduction in testis size in
SCARKO mice as compared to littermate controls is accompa-
nied by a striking decrease in tubular diameter (down to 61% of
the control on day 50) and an even more marked decrease in
lumen formation (down to 32% of the control when expressed as a
percentage of testis volume) [10]. Here we used efferent duct
ligation to explore the ability of SCARKO testes to secrete and
accumulate testicular fluid. In control mice, unilateral ligation of
the efferent ducts for 24 h resulted in a 19% increase in weight of
the ligated testis as compared to the unligated testis (p,0.05)
reflecting active fluid secretion and an intact SC barrier. However
in SCARKO mice, a 7% decrease in testis weight (not significant)
rather than an increase was observed, suggesting that SC fluid
secretion and/or barrier formation were impaired (Table S1).
Perfusion with hypertonic fluid [32] was used to evaluate more
specifically the formation of a functional SC barrier in testes of
peripubertal (day 10, 15, 25, and 35) and adult SCARKO and
control littermates (Figure 1). At least 3 animals were studied at
each of these time points. Despite some variability between
individual animals, as also reported by other investigators [32], a
consistent evolution of barrier formation was observed. At the age
of 10 days all tubular cells, in control (Figure 1A) as well as in
SCARKO mice (Figure 1B), displayed hypertonicity-related
shrinkage, indicating the absence of a functional barrier. On day
15, barrier formation had occurred in most of the tubules from
control mice as evidenced by limitation of cell shrinkage to the
basal compartment (Figure 1C). In SCARKO mice of the same
age no barrier formation was observed (Figure 1D). In 25-day-old
control animals barrier formation was noted in all testicular
tubules (Figure 1E). In SCARKO mice of the same age the
situation was more variable with barrier formation in some tubules
(particularly in those displaying pachytene spermatocyte develop-
ment) and absence of barrier formation in others (Figure 1F). A
similar picture was noted on day 35 (Figure 1G, H). In some
tubules of SCARKO mice, hypertonicity-induced shrinkage of
centrally located cells was seen despite clear signs of (partial)
Table 1. Oligonucleotide primers and probes used for qPCR.
Gene name Gene Accession 59 Primer (Fw)
symbol number 39 Primer (Rv)
Probe
Reproductive Rhox5 NM_008818 Fw: 59-TCATCATTGATCCTATTCAGGGTATG-39
homeobox 5 Rv: 59-CTCTCCAGCCTGGAAGAAAGC-39
Probe: 59-6-FAM-CTCGGAAGAACAGCATGATGTGAAAGCA-TAMRA-39
Synaptonemal Sycp3 NM_011517 Fw: 59-ATGCTTCGAGGGTGTGGG-39
complex protein 3 Rv: 59-TTCCACCAGGCACCATCTTT-39
Steroid 17-a- Cyp17a1 NM_007809 Fw: 59-GGGCACTGCATCACGATAAA-39
hydroxylase/17,20-lyase Rv: 59-GATCTAAGAAGCGCTCAGGCA-39
Claudin 11 Cldn11 NM_008770 Fw: 59-CGTCATGGCCACTGGTCTCT-39
Rv: 59-GGCTCTACAAGCCTGCACGTA-39
Claudin 3 Cldn3 NM_009902 Fw: 59-GCGCCTTGCTGTGTTGCT-39
Rv: 59-AGAGGATCTTGGTGGGTGCAT-39
Zonula occludens 1 ZO-1 NM_001163574 Fw: 59-GGAGCTACGCTTGCCACACT-39
Rv: 59-GGTCAATCAGGACAGAAACACAGT-39
Luciferase Luciferase L4561(from Fw: 59-TCGAAGTATTCCGCGTACGTG-39
Promega) Rv: 59-GCCCTGGTTCCTGGAACAA-39
18S ribosomal RNA Rn18S NR_003278 Fw: 59-CGCCGCTAGAGGTGAAATTC-39
Rv: 59-TTGGCAAATGCTTTCGCTC-39
doi:10.1371/journal.pone.0014168.t001
Table 2. TaqManH Gene Expression Assays used for qPCR.
Gene name Gene Accession
TaqManH Gene
Expression
symbol number
Assay (Applied
Biosystems)
Actinin, alfa 3 Actn3 NM_013456 Mm00496495_m1
Ankyrin 3, node of Ank3 NM_009670 Mm00464776_m1
Ranvier (ankyrin G)
Annexin A9 Anxa9 NM_023628 Mm00499250_m1
Scinderin Scin NM_009132 Mm00485972_m1
Embigin Emb NM_010330 Mm00515881_m1
Myelin protein zero-like 2 Mpzl2 NM_007962 Mm00468397_m1
Occludin Ocln NM_008756 Mm00500912_m1
Junction adhesion Jam3 NM_023277 Mm00499214_m1
molecule 3
Vimentin Vim NM_011701 Mm00449208_m1
Connexin 43 (gap junction Cx43 (Gja1) NM_010288 Mm00439105_m1
protein, alpha 1, 43kDa)
Espin Espn NM_019585 Mm02026930_s1
N-cadherin Cdh2 NM_007664 Mm00483213_m1
doi:10.1371/journal.pone.0014168.t002
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barrier formation at the base of the tubules (Figure 1H). At adult
age, barrier formation was observed in all tubules of control mice
(Figure 1I) and in nearly all tubules of SCARKO mice (Figure 1J).
Quantification of the fraction of tubules with a fully functional
barrier (Figure S1) confirmed the differences in development
between SCARKO and control testes but also showed that in
SCARKO mice the fraction of tubules with an intact barrier
increased from 18.2% at day 25 to 60.1% at day 35 and to 84.7%
at adult age. In adult control mice 99.7% of the tubules displayed
an intact barrier.
Electron microscopic demonstration of delayed and
incomplete barrier formation in SCARKO testes
In confirmation of the findings described above, examination of
the permeation of lanthanum in 10-day-old control (Figure 2A)
and SCARKO (Figure 2B) testes revealed free permeation of the
spaces between SC and between SC and GC, indicating absence
of barrier formation. On day 15, formation of tight junctions
blocking the penetration of lanthanum in the adluminal
compartment was observed in the majority of tubules of testes
derived from control mice (Figure 2C; white arrowheads) and in
some tubules derived from SCARKO mice (Figure 2D; white
arrowheads). Interestingly, the SC lining the basal lamina of
tubules in control testes appeared more mature (elongated shape,
elongated and irregularly shaped nuclei with a prominent and
tripartite nucleolus) than those lining the basal lamina in tubules of
SCARKO testes. Moreover, in SCARKO tubules tight junctions
were observed mainly between more centrally located SC, which
also appeared more mature than their peripherally located
counterparts. In tubules of 25-day-old control mice only very
few SC displayed signs of immaturity and tight junctions
restricting permeation of lanthanum were seen between SC
located at the base of the epithelium (Figure 2E). Barrier formation
could also be observed in some tubules of SCARKO mice
(Figure 2F). In these mice, however, tight junctions were
frequently dislocated to the more centrally located regions of the
seminiferous epithelium that also contained the more mature SC,
resulting in a broadening of the basal compartment, compared to
that of control mice. Moreover, in SCARKO testes, unlike in
control testes, some tubules remained permeable to lanthanum. In
35-day-old control mice a well developed SC barrier preventing
passage of lanthanum was seen in all tubules analyzed (Figure 2G).
In 35-day-old SCARKO mice the formation of tight junctions and
a SC barrier was more prominent than that at 25 days of age but
nonetheless in some tubules variable amounts of lanthanum were
evident in the adluminal compartment (Figure 2H). In adult
control mice passage of lanthanum was blocked in all tubules
(Figure 2I) while in adult SCARKO mice the picture resembled
that observed in 35-day-old SCARKO testes with variable
penetration of lanthanum (Figure 2J).
A more detailed investigation of junction formation was
performed in control and SCARKO testes of 25-day-old, 35-
day-old and adult mice. Representative data from day 35 are
summarized in Figure 3. Similar results were observed at the other
ages. The data indicate the presence of typical tight junctions
blocking the passage of lanthanum in control animals (Figure 3A,
B and C). In SCARKO mice formation of impermeable tight
junctions was observed in some areas (Figure 3D, E and F) but
diverse areas of the epithelium remained permeable to lanthanum
despite the presence of similar junctions (Figure 3G, H and I)
suggesting that the zonulae occludens that encircle the whole
epithelium may contain permeable areas. Further investigations
(including freeze fracture studies) will be required to clarify the
nature of these defects.
Figure 1. Use of hypertonic perfusion to assess the integrity of
the SC barrier. Testes from mice with a SC-selective knockout of the
androgen receptor (SCARKO; panel B, D, F, H, J) and from control
littermates (panel A, C, E, G, I) were subjected to hypertonic perfusion at
day 10 (panel A, B), day 15 (panel C, D), day 25 (panel E, F), day 35 (panel
G, H) and at adult age (panel I, J) as described in the Methods section.
At least 3 animals were studied at each age and representative pictures
have been selected. Black asterisks indicate representative tubules with
shrinkage around cells that are centrally positioned (no functional
barrier). Arrowheads indicate basal compartment shrinkage (presence
of a functional barrier). Scale bars = 50 mm.
doi:10.1371/journal.pone.0014168.g001
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Immunohistochemical evidence for delayed and
incomplete formation of the SC barrier in SCARKO mice
The expression of proteins associated with junctional complexes
was examined using double fluorescent immunohistochemistry so as
to determine both whether expression of proteins could be detected
but also whether they became organized into complexes at
appropriate locations within the seminiferous epithelium. Com-
bined staining for the adaptor protein ZO-1 and F-actin
demonstrated that both proteins were expressed in testes from
control and SCARKO animals (Figure 4). In control mice
colocalization of ZO-1 and F-actin was observed, parallel with the
basal lamina, reflecting the organization/maturation of complexes
within the SC barrier. This colocalization (Figure 4F, I, L: white
arrowheads) became particularly prominent from day 25 on. As
expected, F-actin staining was observed not only at the level of the
tight junctions but also at the level of the apical ectoplasmic
specializations (Figure 4G, J: white boxes). In SCARKO testes,
staining for ZO-1 was quite diffuse until day 35 (Figure 4N, Q).
Prominent staining of F-actin could be observed, however at the
base of the tubules (Figure 4O, R, U, X). From day 35 onwards,
colocalized staining for ZO-1 and F-actin, suggesting barrier
formation, could clearly be observed at the base of the tubules
despite residual ZO-1 staining in the center (Figure 4S). Barrier
formation was even more prominent in the adult testis but junctions
were located further away from the periphery of the tubules than in
littermate controls (Figure 4V: brackets).
Combined staining for CX43 (gap junctions) and ESPN (basal
and apical ectoplasmic specializations) also revealed expression of
both proteins and provided evidence of delayed organization of
junctions in SCARKO testes (Figure S2). On day 20 only diffuse
staining was noted in SCARKO as well as control testes (Figure
S2M, N, O and A, B, C respectively). In 25-day-old controls,
colocalized staining of ESPN and CX43 was noted, parallel with
the basal lamina in a location appropriate for the formation of the
SC barrier complex (Figure S2F: white arrowheads). ESPN
staining was also noted within the adluminal compartment and
was particularly prominent around the heads of the elongated
spermatids from day 35 on, consistent with the formation of apical
ectoplasmic specializations (Figure S2H, K). In 25- and 35-day-old
SCARKO mice both ESPN (Figure S2Q, T) and CX43 (Figure
S2R, U) staining appeared as a non-homogenous filiform network
within the tubules with only sporadic indications of more intensive
accumulations near the base of the tubules. In adult SCARKO
mice many tubules showed tortuous strands of colocalized CX43
and ESPN, mostly oriented perpendicular rather than parallel to
the basal lamina (Figure S2V: white arrowheads).
To investigate whether changes in the expression of molecules
related to tight junction formation in the testis might be involved
in the disturbed development of the SC barrier in SCARKO mice
we also studied the transcript levels of a number of relevant genes.
Figure 5 summarizes results selected from an earlier microarray
study (day 8–20) [19] and data from a new, independent and more
detailed qPCR time study (day 8–35). The qPCR data revealed a
marked and significant decrease in the transcript level of Cldn3
(Figure 5B) in SCARKO testes as compared to control testes from
day 15 on. A tendency towards lower expression levels in
SCARKO testes was also noted for Cdh2 (Figure 5D), Espn
(Figure 5E) and Jam3 (Figure 5I) from day 10 on (confirming the
microarray data) but significant differences were only found from
day 15 on (Espn) or from day 20 on (Cdh2 and Jam3). Similarly, a
limited decrease in the transcript level of Cldn11 (Figure 5A) was
seen over the entire period studied. Given the limited number of
mice studied (n= 3) significant effects were observed only at day 8,
12 and 15. In a recent study on a larger number of mice (n = 10),
however, a significant decrease in the expression of Cldn11 in
SCARKO testes was confirmed over the entire period studied (day
4–50) [23]. No or only minor differences in expression level were
observed for Cx43 (Figure 5G), Ocln (Figure 5H) and Vim
(Figure 5C) (again confirming the microarray data). ZO-1
transcript levels (Figure 5F) tended to be lower from day 20 on
but significant differences were noted only on day 35.
Abnormal positioning of SC nuclei and abnormal
localization of vimentin in SCARKO testes
Despite the fact that important biochemical parameters of SC
maturation behave similarly in SCARKO and control animals
[38], the electron microscopy studies described above showed
clear disturbances in nuclear maturation and localization in
SCARKO testes. Combined staining for GATA1 and VIM was
used to study nuclear localization and its relationship to
cytoskeletal development in SCARKO and control testes
(Figure 6). In 20- and 25-day-old control mice nearly all SC
nuclei were found at the periphery of the tubules close to the basal
lamina (Figure 6C, F). However, in SCARKO littermates of the
same ages, SC nuclei were found at variable locations, often
forming one- or two-layered rings positioned more centrally in the
Figure 2. Comparison of barrier formation in 10-, 15-, 25-, 35-day-old and adult control and SCARKO testes. Immersion fixation with
lanthanum and electron microscopic evaluation of testes from mice with a SC-selective knockout of the androgen receptor (SCARKO; panel B, D, F, H
and J) and from control littermates (panel A, C, E, G and I) were performed as described in the Methods section. At least 3 animals were studied at
each age and representative pictures have been selected. In testes derived from 10-day-old mice lanthanum (black arrowheads) is seen in the
intercellular spaces throughout all the seminiferous tubules reflecting absence of barrier formation in control as well as SCARKO testes (panel A and B
respectively). Initial formation of tight junctions and a Sertoli cell (SC) barrier can be seen in 15-day-old control and SCARKO testes (panel C and D). In
control testes mature Sertoli cells (SC) are lining the tubular lamina. Tight junction and barrier formation (white arrowheads) inhibits penetration of
lanthanum (black arrowheads) into the adluminal compartment. In SCARKO tubules peripherally located SC (panel D: SC1, SC2, SC3), displaying signs
of immaturity, allow penetration of lanthanum (black arrowheads). Formation of a tight junction barrier may be noted between more centrally
located SC (panel D: SC4, SC5) that also display more advanced signs of maturation. At the age of 25 days barrier formation (white arrowheads) is
evident in all tubules from control animals and in some tubules from SCARKO mice. In control testes mature SC lining the basal lamina produce a
lanthanum impermeable barrier (panel E). In some SCARKO tubules tight junction and barrier formation is observed between more centrally located
SC (panel F: SC1, SC2) showing signs of maturity. Lanthanum permeation is observed between peripherally located less differentiated SC (panel F:
SC3, SC4) resulting in a broadened basal compartment. At the age of 35 days restriction of lanthanum to the basal compartment is observed in all
tubules of control mice (panel G) and in some tubules of SCARKO mice (panel H). Panel G shows a well developed SC barrier typical for tubules of 35-
day-old control mice. Note the presence of primary spermatocytes (pSPC) in the adluminal compartment and a spermatogonium (SPG) close to the
basement membrane. In 35-day-old SCARKO tubules permeable tight junctions may be noted between and above immature basally positioned SC
(panel H: black arrowhead between SC1 and SC2). Impermeable junctions (white arrowheads) are noticed in the upper region containing more
mature SC (panel H: SC3). In adult control mice no permeable tubules were found (panel I). The SC barrier between mature SC (white arrowheads) is
usually located in the more basal part of the SC. In adult SCARKO mice however lanthanum could still be observed between and above immature SC
(panel J: black arrowheads). Nc: prominent nucleoli; PTM: peritubular myoid cell.
doi:10.1371/journal.pone.0014168.g002
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tubules (Figure 6M, P: black arrowheads). In control testes, VIM
staining surrounded the peripherally located nuclei (Figure 6C, F,
I, L) whereas in SCARKO testes only faint VIM staining was seen
around the centrally located nuclei, but anchor-like structures with
radial extensions were evident apparently connecting the SC
nuclei to the basal lamina (Figure 6M, P, S, V: white arrowheads).
Comparable anchor-like structures were observed in 20-day-old
controls (Figure 6C: white arrowheads). Examination of testes of
older control animals (day 35 or adult: Figure 6I, L) revealed
further migration of SC nuclei to the periphery of the tubules and
perinuclear localization of VIM with stalk-like extensions to the
centre of the tubules. In SCARKO animals, progressive migration
of SC nuclei to a more basal location was observed in some
tubules, but in many tubules centrally located SC nuclei con-
nected to the basal lamina by VIM anchors remained evident
(Figure 6S, V).
Figure 3. Lanthanum penetration and barrier formation in testes derived from 35-day-old control and SCARKO testes. A typical tight
junction impeding further penetration of lanthanum in a day 35 control testis is shown in panel A, B and C. Panel B represents an enlargement of the
boxed area in panel A showing an impermeable barrier. A further enlargement of the boxed area in panel B is shown in panel C. Black arrowheads
show lanthanum below the tight junction that starts at the white arrow. So called ‘‘kissing points’’ of the tight junction can be seen (white
arrowheads) within the ectoplasmic specialization. An impermeable barrier in a day 35 SCARKO testis is illustrated in panel D, E and F (black arrow).
Panel E and F represent enlargements of the boxed area’s indicated in panel D and E respectively. Cisternae of smooth endoplasmic reticulum
(asterisk) surrounding a tight junction may be noted in panel F. Panel G, H and I show another area of the same SCARKO testis where lanthanum
penetrates between two SC (SC1 and SC2). Panel H represents an enlargement of the area in the black square in panel G. An enlargement of the more
adluminally located area in the white square of panel G is shown in panel I. The bracket in panel I shows an ectoplasmic specialization (ES) that acts as
a barrier for further penetration of lanthanum. Nonetheless lanthanum may be noted above this barrier (black arrowheads). Pictures are
representative for at least 3 animals studied.
doi:10.1371/journal.pone.0014168.g003
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Novel targets of androgen action in SC related to cell
adhesion and cytoskeletal dynamics
Previous studies have focused on the potential role of molecules
that are already known to play a role in tubular restructuring
(including the above described cell adhesion molecules and
cytoskeletal elements). In search for novel and potentially relevant
targets for androgen action we screened the data from an earlier
microarray study comparing transcript levels in SCARKO and
control animals between day 8 and 20 [19] for genes displaying
striking differential expression patterns. Particular attention was
paid to genes involved in cell adhesion and cytoskeletal dynamics.
The original microarray data and an independent and more
detailed qPCR time study for 6 potentially relevant genes are
summarized in Figure 7. Four of the studied genes (Actn3, Ank3,
Anxa9 and Scin) have been related to cytoskeletal remodeling, two
of them (Emb, Mpzl2) encode cell adhesion molecules. Apart from
Scin that showed significantly higher expression levels in SCARKO
testes, all the other genes studied were down-regulated in
SCARKO mice. The qPCR data essentially confirmed the
differences in expression level suspected from the microarray
data. For the 6 genes investigated, a tendency towards differential
expression was evident from day 10 or from day 12 (Emb) onwards.
Statistically significant differences were noted from day 8 on for
Ank3 (Figure 7B), from day 10 on for Scin (Figure 7D) and from day
12 on for Actn3 (Figure 7A), Anxa9 (Figure 7C), Emb (Figure 7E)
and Mpzl2 (Figure 7F). The microarray data suggest a decrease in
transcript levels after day 15 for most of the genes studied. As
previously discussed [19], this is an artifact caused by the
increasing contribution of developing GC to the total amount of
RNA, particularly in controls. This increase is not observed in the
qPCR data since these data are corrected for exogenously added
luciferase and accordingly reflect transcript levels per testis.
To confirm that the described genes are expressed in SC,
expression levels were compared in whole testis extracts and in
enzymatically prepared fractions enriched for interstitial or tubular
cells (Data S1; Figure S3). Part of the latter fraction was subjected
to hypotonic shock to eliminate GC and to obtain further
enrichment for SC. Rhox5, Sycp3 and Cyp17a1 were included as
typical representatives of genes expressed in SC, GC and
interstitial (Leydig) cells respectively. It should be noted that, like
Figure 4. Evolution of SC barrier formation in testes of SCARKO and control mice. SC barrier formation was studied by combined staining
for zonula occludens 1 (ZO-1; green) and filamentous actin (F-actin; red) on frozen sections of testes derived from SCARKO and control littermates at
the indicated ages as described in the Methods section. Localization of F-actin (panel A, D, G and J) and ZO-1 (panel B, E, H and K) in testes from
control mice is shown at day 20 (panel A, B), day 25 (panel D, E), day 35 (panel G, H) and at adult age (panel J, K). The corresponding merged images
of F-actin, ZO-1 as well as of DAPI (blue) staining are shown in panels C (day 20), F (day 25), I (day 35) and L (adult). Localization of F-actin (panel O, R,
U and X) and ZO-1 (panel N, Q, T and W) in testes from SCARKO mice is shown at day 20 (panel O, N), day 25 (panel R, Q), day 35 (panel U, T) and at
adult age (panel X, W). The corresponding merged images of F-actin, ZO-1 as well as of DAPI (blue) staining are shown in panels M (day 20), P (day
25), S (day 35) and V (adult). For each genotype 3 animals were studied at each time point. Colocalization of F-actin and ZO-1 (yellow staining; white
arrowheads) in wavy bands parallel with the basal lamina, consistent with SC barrier formation, may be noted in control animals from day 25 on and
in SCARKO mice from day 35 on. Also note a widening of the basal compartment in adult SCARKO testes (panel V: brackets). Prominent F-actin
staining can also be observed in the central region of the tubules of control mice coinciding with apical ectoplasmic specializations (panel G, J: white
boxes). Scale bars = 100 mm.
doi:10.1371/journal.pone.0014168.g004
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Rhox5, the 9 selected genes displayed lower expression levels in the
interstitial than in the tubular cell fraction and that hypotonic
treatment of the latter fraction caused a further increase in
transcript levels suggesting that SC are the main source of the
studied transcripts.
Discussion
The data summarized here show that selective ablation of the
AR in SC affects SC maturation, results in delayed and incomplete
formation of the SC barrier, and changes the expression pattern of
several genes related to cell adhesion and cytoskeletal development
in SC.
SC maturation is a complex process that may be influenced by
hormones (including androgens, FSH, thyroid hormone…), local
regulatory factors (including growth factors, cytokines and
interactions with neighboring somatic cells and GC) and testicular
localization (intrascrotal or cryptorchid) [25,39–44]. Testicular
androgens undoubtedly play a crucial role but the nature of their
effects and the underlying molecular and cellular mechanisms
remain only partially understood. Some 30 years ago already it
was noted that interference with androgen production during the
first 32 days of life precluded the expected maturational changes in
the nucleus, nucleolus and cytoplasm of rat SC without affecting
the development of SC tight junctions [45]. The SCARKO model
offers a unique opportunity to explore whether these effects
depend on cell-autonomous activation of the AR in SC.
Surprisingly, initial observations in the SCARKO model
indicated that several important parameters reflecting SC
maturation develop normally in the absence of AR expression in
SC and even in the general absence of AR expression (ARKO
mice with ubiquitous ablation of the AR) [38]. As in WT animals,
SC in SCARKO and ARKO mice show a rapid decline in anti-
Mu¨llerian hormone (AMH) expression during the first weeks of life
and an early pubertal rise in the expression of cyclin-dependent
kinase inhibitor 1B (CDKN1B or p27kip1; marking the end of SC
Figure 5. mRNA expression profiles of genes related to tight junction components and intermediate filaments. Testicular transcript
levels for Cldn11 (panel A), Cldn3 (panel B), Vim (panel C), Cdh2 (panel D), Espn (panel E), ZO-1 (panel F), Cx43 (panel G), Ocln (panel H) and Jam3 (panel
I) were measured by qPCR and corrected for exogenously added luciferase mRNA as described in the Methods section. qPCR data (bars) represent the
mean6 SEM of measurements on 3 SCARKO and 3 control testes studied on day 8, 10, 12, 15, 20, 25 and 35 postnatal (p.n.). The mean transcript level
of the control measured on day 10 was arbitrarily assigned a value of 100. Statistically significant differences between SCARKO and control animals
are indicated by an asterisk. The original microarray data (lines) are shown for comparison. Microarray measurements were performed on a pool of
mRNA derived from testes of 3 SCARKO and 3 control mice (day 8, 10, 12, 16, 20 p.n.) [19]. Values (relative signal intensities) were expressed relative to
the value of the control on day 10 (arbitrarily assigned a value of 100). Note that microarray measurements reflect transcript levels in a given amount
of RNA. Due to the increasing contribution of germ cells selectively in control mice and not in SCARKO mice (which develop a block in meiosis), SC
transcripts become diluted in the total amount of RNA and microarrays may fail to demonstrate differences in the expression of SC genes after day
15. The correction of the qPCR data for exogenously added luciferase circumvents this problem by reflecting transcript levels per testis [19].
doi:10.1371/journal.pone.0014168.g005
Androgens and Sertoli Cells
PLoS ONE | www.plosone.org 10 November 2010 | Volume 5 | Issue 11 | e14168
proliferation), GATA1 (an important transcription factor in SC)
and clusterin (CLU or SGP2; one of the main SC secreted
proteins). Nonetheless, SCARKO SC are obviously unable to
support completion of meiosis and spermatid formation and, at the
onset of meiosis (day 10), their gene expression pattern differs
markedly from that observed in testes and SC from normal
controls [19]. The data presented here provide novel information
and further support the contention that activation of the AR in SC
is mandatory to allow the changes in tubular architecture and
junction dynamics that accompany normal tubular development
and that are needed to allow initiation of spermatogenesis.
Evaluation of SC barrier formation by 3 different techniques
(hypertonic perfusion, examination of lanthanum permeation by
electron microscopy and immunohistochemical analysis) indicates
that barrier formation is a progressive process in which not all
aspects may be completed at the same time. In control mice,
hypertonic perfusion experiments and lanthanum permeability
studies suggest initial barrier formation from day 15 onwards,
whereas immunohistochemical studies indicate that complete
organization of tight junction complexes may take at least 10
more days. Although differences in sensitivity of the various
techniques cannot be excluded, these findings are reminiscent of
earlier observations in the rat showing that hypertonic perfusion or
lanthanum penetration experiments point to the formation of a
functional barrier between day 16 and 19 whereas a more
quantitative evaluation based on the penetration of labeled Cr-
EDTA or albumin indicates that it may take until day 44 before
the tightness of the adult barrier is achieved [32,46]. Our
experiments in the SCARKO mouse model show unequivocally
that an active AR in SC is mandatory for timely and complete
barrier formation. These findings confirm and extend earlier data
showing a defective barrier in Tfm mice or Arflox(ex1-neo)/Y; AMH-
Cre mice, two models in which AR ablation is not limited to SC
[28,30]. Hypertonic perfusion studies indicate that many tubules
in the SCARKO still form a barrier that protects adluminally
located cells from shrinkage. The formation of this barrier,
however, is clearly delayed (by 5–10 days). Furthermore, despite
indications of the presence of a barrier some tubules display
regional shrinkage of adluminally located GC suggesting that at
least at some places the barrier must be leaky or incomplete.
Figure 6. Localization of SC nuclei and associated cytoskeleton in testes of SCARKO and control mice. Testes were derived from
SCARKO mice and control littermates at the indicated ages. SC nuclei and the associated cytoskeleton were studied by immunostaining for GATA
binding protein 1 (GATA1; red) and the intermediate filament protein vimentin (VIM; green) respectively. Expression of GATA1 (panel A, D, G and J)
and VIM (panel B, E, H and K) in testes from control mice is shown at day 20 (panel A, B), day 25 (panel D, E), day 35 (panel G, H) and at adult age
(panel J, K). The corresponding merged images of GATA1, VIM as well as of DAPI (blue) staining are shown in panels C (day 20), F (day 25), I (day 35)
and L (adult). Expression of GATA1 (panel O, R, U and X) and VIM (panel N, Q, T and W) in testes from SCARKO mice is shown at day 20 (panel O, N),
day 25 (panel R, Q), day 35 (panel U, T) and at adult age (panel X, W). The corresponding merged images of GATA1, VIM as well as of DAPI (blue)
staining are shown in panels M (day 20), P (day 25), S (day 35) and V (adult). For each genotype 3 animals were studied at each time point. In control
mice SC nuclei become localized to the basal portion of the epithelium from day 25 on. Moreover, nuclei are surrounded by a prominent layer of VIM.
In SCARKO mice many nuclei fail to migrate to the periphery of the tubules (black arrowheads) and anchor-like structures of VIM (white arrowheads)
may be noticed connecting these nuclei to the basal lamina (as can also be seen in day 20 control mice). Scale bars = 25 mm. The data shown are
representative for 2 independent time studies.
doi:10.1371/journal.pone.0014168.g006
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Electron microscopy and lanthanum permeation studies confirm
the presence of functional tight junctions in SCARKO testes.
Interestingly, however, these junctions are not found between the
most peripherally located SC that apparently show signs of
immaturity, but between SC that are located more centrally in the
tubules and that display a higher degree of maturation. Here too,
studies in 35-day-old and adult SCARKO testes indicate that,
despite the formation of tight junctions, lanthanum may be seen in
the adluminal compartment of some tubules. Immunohistochem-
ical evaluation of the development of the SC barrier in control and
SCARKO mice further confirms the delayed and incomplete
barrier formation in the SCARKO testes. In control mice ‘wavy
bands’ of colocalized CX43 and ESPN as well as ZO-1 and F-
actin were localized parallel with and close to the basal lamina
from day 25 onwards. In SCARKO mice, colocalization of ZO-1
and F-actin at the base of the tubules only became evident from
day 35 onwards and colocalization of CX43 and ESPN was
observed only in the adult testis. Moreover, intense immunostain-
ing for these proteins was located further from the periphery of the
tubule and perpendicular to the basal lamina rather than parallel
to it in SCARKO mice on and after day 35. A similar formation of
lanthanum-impermeable junctions perpendicular to the basal
lamina has been described in rats after prenatal treatment with
busulphan [47].
At present we can only speculate on the mechanisms by which
androgens may affect SC barrier formation. Earlier studies
suggested that androgens may be essential for the expression of
Cldn3, a junction protein that associates specifically with newly
formed tight junctions and that, according to recent data, might
act as a sealing component that delineates the transiently existing
translocation compartment allowing transfer of leptotene sper-
matocytes through the SC barrier [30,48]. Our data confirm
markedly decreased Cldn3 transcript levels in SCARKO testes
from day 15 onwards but also show that differences in transcript
levels of other tight junction elements such as Cldn11 and Jam3 are
already evident at a much earlier time points (days 4 and 10
respectively) [23]. Cldn11 is known to be essential for tight junction
formation and male fertility [49] and the dependence of its
expression on androgens has been documented also in other
studies [22,50,51]. However it is well established that the mature
basal SC barrier consists of multiple junctional complexes with
multiple protein constituents (see reviews by Cheng and co-
workers [26,27,52]) and from our gene expression data it is evident
that, apart from the claudins, the expression of Cdh2 and Espn (and
to a lesser extent ZO-1) are all impaired in SCARKO mice
whereas no consistent differences in transcript levels were observed
for Cx43 and Ocln. In addition, it should be noted that the SC
barrier is a very dynamic structure and that apart from transcript
levels also protein levels and posttranslational modifications
affecting localization and interaction between the various
components may be important for correct function. The
immunohistochemical data shown in this study clearly support
the contention that androgens not only affect the level of
expression of tight junction related molecules but also their
distribution/localization. Recent data have stressed the essential
role of ether-lipids in barrier dynamics and correct positioning of
tight junction proteins [48]. Given the well-known effects of
androgens on lipogenesis [53], it would be worthwhile to study
whether androgens affect ether lipid metabolism in SC. Further-
more, and along the same lines, it has been demonstrated that
androgens may alter barrier dynamics by affecting the kinetics of
endocytosis and recycling of barrier-related proteins [52].
Figure 7. mRNA expression profiles of new candidate androgen regulated target genes. Genes related to cytoskeletal dynamics (Actn3:
panel A; Ank3: panel B; Anxa9: panel C; Scin: panel D) or cell adhesion (Emb: panel E; Mpzl2: panel F) were selected based on their expression profile in
a microarray time study (day 8–20) [19]. Transcript levels were measured by qPCR and corrected for exogenously added luciferase mRNA as described
in the Methods section. qPCR data (bars) represent the mean6 SEM of measurements on 3 SCARKO and 3 control testes studied on day 8, 10, 12, 15,
20, 25 and 35 postnatal (p.n.). The mean transcript level of the control measured on day 10 was arbitrarily assigned a value of 100. Statistically
significant differences between SCARKO and control animals are indicated by an asterisk. The original microarray data (lines) are shown for
comparison. Microarray measurements were performed on a pool of mRNA derived from testes of 3 SCARKO and 3 control mice (day 8, 10, 12, 16, 20
p.n.). Values (relative signal intensities) were expressed relative to the value of the control on day 10 (arbitrarily assigned a value of 100).
doi:10.1371/journal.pone.0014168.g007
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Our data confirm earlier observations indicating a parallelism
between barrier formation and initiation of meiosis [32]. Given the
increasing evidence for bilateral interactions between GC and SC in
the dynamics of barrier function [27,54], this raises the question
whether androgens might affect barrier development indirectly by
promoting meiotic progression. No unambiguous answer can be
provided to this important issue at the present time. Few studies
have addressed barrier formation in mice with a primary defect in
GC affecting meiotic progression. Normal barrier formation -as
judged from perfusion with a hypertonic fixative- was observed in
mice with theWeaver mutation that causes a variable disturbance in
GC development with some tubules containing only spermatogonia
and others showing only absence of elongated spermatids [55]. Also
in W/Wv mice [56] in which no spermatogenic cells are present in
the seminiferous epithelium it has been demonstrated that SC
junction formation develops normally [57] and that SC cytology
and cytoskeleton are only minimally affected [58]. Lumen
formation, suggesting polarized secretion by SC, has been observed
in Dazl2/2 mice that show a spermatogenic arrest at the leptotene
stage of meiotic prophase I [59]. Similarly, inter-SC tight junction
formation has been shown to remain intact in rats made GC
depleted by a vitamin A deficient diet [60]. Conversely, increased
permeability of the SC barrier and impaired tissue remodeling have
recently been described in mice in which terminal differentiation of
SC fails due to a SC-selective inactivation of the retinoblastoma
protein [61]. Taken together these data suggest that at least part of
the defect in barrier formation in SCARKO mice may directly be
caused by defective SC function.
One of the other defects observed in SC lacking AR (apart from
their inability to support timely and complete barrier formation
and progression through meiosis) is the failure of the nucleus to
adopt its typical position close to the basal lamina. This defect was
also noticed by other investigators [22]. In this paper analysis of
SC maturation in immature SCARKO mice using electron
microscopy points to a failure of nuclear maturation. Signs of
immaturity, such as irregular nuclear shape and condensed
chromatin deposits on the nuclear membrane, have previously
been described in SCARKO-Jsd mice [62]. Unexpectedly, in
pubertal SCARKO mice more basally located nuclei tend to show
more signs of immaturity than centrally located nuclei. The
mechanisms underlying this maturational defect remain unclear.
Given the alleged role of the cytoskeleton in the polarization of SC
and in the positioning of its major organelles [63], and given the
indications that the AR may affect cytoskeletal dynamics in SC
[15], we investigated the expression and localization of vimentin in
developing SC. Over the entire period studied (day 8–35) we did
not observe decreased transcript levels for vimentin as claimed by
other investigators [22]. Nonetheless, clear differences in the
localization of vimentin staining were seen in SC of SCARKO and
control mice. In control animals the vimentin cytoskeleton
surrounded the SC nuclei with extensions directed towards the
center of the tubules. In the SCARKO testis, and particularly in
cells with centrally located nuclei, vimentin was mainly found in
anchor-like structures connecting the lower pole of the nucleus to
the most peripheral part of the tubule close to the basal lamina.
Whether this change is causally related to the absence of androgen
action or whether it is just a reflection of the lack of normal cell
polarization remains to be investigated.
A search for new potentially relevant androgen target genes
related to cell adhesion and cytoskeletal dynamics that might be
differentially expressed in SCARKO and control animals during
early puberty, revealed at least 6 candidates. ACTN3 (actinin-a3) is
a cytoskeletal actin-binding protein and a member of the spectrin
superfamily. It is found in anchoring junctions and, besides binding
to actin filaments, it associates with cytoskeletal elements, signaling
molecules and with the cytoplasmic domains of transmembrane
proteins and ion channels [26,64]. ANK3 (ankyrin 3) is a member of
the ankyrin protein family and links integral membrane proteins to
the spectrin-based cytoskeleton. It is thought to play a role in the
polarized distribution of proteins to specific subcellular sites [65].
ANXA9 (annexin A9) belongs to the annexins, a family of
evolutionary conserved proteins characterized by their ability to
interact with membrane phospholipids in a Ca++-dependent way.
These proteins have been implicated in membrane organization,
membrane-cytoskeleton contacts and vesicular transport. A unique
feature of ANXA9 is that its Ca++-binding sites are dysfunctional
and accordingly its function is unknown [66]. Interestingly, its
promoter binds GATA1 [67], an important transcription factor in
SC, the expression of which we monitored in our samples. SCIN
(scinderin) is an actin-severing protein reported typically in tissues
demonstrating a high secretory activity. In bovine SC it was shown
to accumulate within the cytoplasm near the base of the cells in a
stage-specific manner suggesting a potential role in the regulation of
tight junction permeability [68]. EMB (embigin) is a cell adhesion
molecule belonging to the immunoglobulin superfamily and
involved in cell-extracellular matrix interactions during develop-
ment [69]. Increased expression has been correlated with the
appearance of highly organized luminal and ductal structures [70].
Its congener basigin (ablation of which results in male infertility) also
seems to be involved in the translocation of monocarboxylate
transporters to the plasma membrane [71,72]. MPZL2 (myelin
protein zero-like 2) is also a member of the immunoglobulin
superfamily expressed in various epithelia. It has been shown to
mediate cell adhesion through homophilic interaction and some
data suggest association with the cytoskeleton [73]. Interestingly,
recent data point to a role in the control of the permeability of the
blood-cerebrospinal fluid barrier [74]. For all of these genes, we
present evidence that SC are their main or only site of cellular
localization, indicating that they may contribute to the observed
effects of the SCAR on cell maturation, cell interactions and tubular
restructuring.
In conclusion, targeted ablation of AR from SC does not
completely prevent the formation of an anatomical and functional
barrier defining basal and adluminal compartments within the
seminiferous epithelium. However, barrier formation is delayed and
defects are observed in many tubules. The defective barrier
formation is accompanied by disturbances in the nuclear maturation
process and in SC polarization resulting in aberrant positioning of
cytoskeletal elements such as vimentin. The observed developmental
defects in SCARKO SC are accompanied by disturbances in the
expression of well known molecules involved in cell adhesion and
cytoskeleton building but marked differences were also observed in a
number of previously unstudied molecules that may be related to
these functions. These findings support the contention that absence
of the AR in SC has major implications for the pubertal and
postpubertal events of tubular restructuring that are essential to allow
normal initiation and progression of spermatogenesis.
Supporting Information
Data S1
Found at: doi:10.1371/journal.pone.0014168.s001 (0.04 MB
DOC)
Figure S1 Quantitative evaluation of the formation of a
functional SC barrier in SCARKO and control testes. Testes
derived from SCARKO and control mice at the indicated ages
(day 25, day 35 and adult; at least 3 animals at each time point)
were evaluated for the presence of a functional SC barrier after
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perfusion with a hypertonic solution. Testes were embedded,
sectioned and stained as described in Materials and Methods. SC
barrier formation was evaluated by light microscopy for the
indicated numbers (n) of tubular sections. Barrier formation was
scored as ’fully functional’ when hypertonicity-induced shrinkage
was limited to cells in the basal compartment (panel A), as
’intermediate’ when shrinkage was not limited to the basal
compartment but was also observed in other peripherally located
cells (panel B) and as ’defective’ when shrinkage was also seen in
centrally located cells (panel C). Results are summarized in panel
D. Barrier formation is delayed in SCARKO tubules but the
number of tubules showing an intermediate/defective barrier
decreases as a function of age. The scale bar in panel A, B and C
represents 50 mm.
Found at: doi:10.1371/journal.pone.0014168.s002 (1.31 MB TIF)
Figure S2 SC barrier formation in SCARKO and control testes
studied by combined staining for connexin 43 and espin. SC
barrier formation was studied by combined staining for the gap
junction protein connexin 43 (CX43; red) and for espin (ESPN;
green) a marker of basal and apical ectoplasmic specializations, as
explained in Materials and Methods. Localization of CX43 (panel
A, D, G and J) and ESPN (panel B, E, H and K) in testes from
control mice is shown at day 20 (panel A, B), day 25 (panel D, E),
day 35 (panel G, H) and at adult age (panel J, K). The
corresponding merged images of CX43, ESPN as well as of DAPI
(blue) staining are shown in panels C (day 20), F (day 25), I (day 35)
and L (adult). Localization of CX43 (panel O, R, U and X) and
ESPN (panel N, Q, T and W) in testes from SCARKO mice is
shown at day 20 (panel O, N), day 25 (panel R, Q), day 35 (panel
U, T) and at adult age (panel X, W). The corresponding merged
images of CX43, ESPN as well as of DAPI (blue) staining are
shown in panels M (day 20), P (day 25), S (day 35) and V (adult).
For each genotype 3 animals were studied at each time point. In
controls ESPN and CX43 are colocalized (yellow staining; white
arrowheads), parallel with the basal lamina, in a location
appropriate for the SC barrier, from day 25 on (panel F, I and
L). In the adult SCARKO (panel V), colocalized ESPN and CX43
(white arrowheads) may be noted as tortuous strands mostly
oriented perpendicular rather than parallel to the basal lamina.
Scale bars = 50 mm.
Found at: doi:10.1371/journal.pone.0014168.s003 (2.84 MB TIF)
Figure S3 Testicular localization of transcripts of genes related
to the cytoskeleton or cell adhesion. Testes from 20-day-old mice
were separated in an interstitial fraction and a tubular fraction by
enzymatic digestion as described in Data S1. Part of the tubular
fraction was subjected to hypotonic treatment to destroy germinal
cells and enrich SC. Transcript levels were measured by qPCR in
RNA extracts from whole testes, interstitial fraction, tubular
fraction and tubular fraction enriched for SC (indicated as
hypotonic shock). All measurements were corrected for Rn18S.
The transcript level measured in whole testis extract was
arbitrarily assigned a value of 100 and relative expression levels
were calculated for the other fractions. The depicted genes include
a marker for SC (Rhox5: panel A), GC (Sycp3: panel B) and
Leydig cells (Cyp17a1: panel C), cytoskeletal genes (Actn3: panel
G; Ank3: panel H; Anxa9: panel I and Scin: panel J) and genes
encoding cell adhesion molecules (Emb: panel K; Mpzl2: panel L;
Cldn11: panel D; Cldn3: panel E and Jam3: panel F). One
representative experiment out of three independent experiments is
shown.
Found at: doi:10.1371/journal.pone.0014168.s004 (0.58 MB TIF)
Table S1 Change in testis weight after efferent duct ligation in
SCARKO and control mice. Testis weight was measured 24 h
after efferent duct ligation (EDL) in SCARKO and control mice of
the indicated ages. Efferent duct ligation was performed as
described [4]. In control animals a weight gain (approximately 19
%) was consistently observed in the ligated testis as compared to
the contralateral sham operated testis. In SCARKO testes the
weight of the ligated testis tended to be lower than that of the
unligated testis. Statistical analysis (paired t-test) on the pooled
data of 74- and 380-day-old mice revealed a significant (p # 0.05)
difference in ligated and unligated testis weight for the control
animals (125.4 6 7.2 mg (mean 6 SEM) and 105.3 6 4.2 mg
respectively). The difference in weight between the ligated and
unligated SCARKO testes (32.06 3.0 mg and 33.36 2.6 mg) was
not statistically significant.
Found at: doi:10.1371/journal.pone.0014168.s005 (0.05 MB
DOC)
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